The company offers a growing range of proprietary products and solutions in leading-edge segments and also includes two very high-potential subsidiaries: Protéus in biotechnology and Enersens in high-performance insulation. Boasting especially high standards, PCAS generated net sales of €179,1 million in 2015 and employs more than 900 people in six countries.
PCAS develops and produces complex molecules for life sciences and innovative technologies. As a result of its major R&D investments and extensive international presence, PCAS is an industrial partner of market-leading major global groups.